menu
    • menu

    Company profile for Aclipse Therapeutics

    NEW Drugs in Dev: 2
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aclipse Therapeutics is an innovative biopharmaceutical company that focuses on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel form of an existing drug that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data...
    Aclipse Therapeutics is an innovative biopharmaceutical company that focuses on developing novel and highly differentiated drugs to address diseases with high unmet medical needs. Our strategy is reducing clinical development risk by combining a new and druggable understanding of disease pathways with a novel form of an existing drug that inhibits these pathways, allowing us to build upon existing nonclinical and clinical data while creating a significant patent barrier-to-entry.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aclipse TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    170 N Radnor Chester Rd, Radnor Township, Pennsylvania US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aclipsetherapeutics.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aclipse-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aclipse to Collaborate with Mayo Clinic Ph 2 Trial of M107
    Aclipse to Collaborate with Mayo Clinic Ph 2 Trial of M107

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111165233/en/Aclipse-Therapeutics-to-Collaborate-with-Mayo-Clinic-on-Phase-2-Clinical-Development-of-M107-for-the-Treatment-of-Gastroparesis

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Aclipse Therapeutics to Present ALS Development Program at Symposia
    Aclipse Therapeutics to Present ALS Development Program at Symposia

    07 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241107095243/en

    BUSINESSWIRE
    07 Nov 2024
    Share Share
    Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang
    Aclipse Expands Drug Development Pipeline with Agreement with Chong Kun Dang

    14 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230914038839/en

    BUSINESSWIRE
    14 Sep 2023
    Share Share
    Aclipse Announces $2.2 Million Grant from UK’s Medical Research Council
    Aclipse Announces $2.2 Million Grant from UK’s Medical Research Council

    26 Jan 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210126005044/en/Aclipse-Therapeutics-Announces-2.2-Million-Grant-from-UK%E2%80%99s-Medical-Research-Council-for-Development-of-M102

    BUSINESSWIRE
    26 Jan 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search